Alcon vs Biogen

Alcon (ALC), health care, and Biogen (BIIB), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Biogen is worth $37.1B on the stock market and Alcon $35.6B: Biogen is valued at 4% more. Alcon trades at 53.7 times earnings and Biogen at 109. Over the past year Alcon's share price has moved -2.82% and Biogen's +49.1%.

Key facts

Alcon market value
$35.6B
Biogen market value
$37.1B
Alcon P/E
53.7
Biogen P/E
109
Alcon revenue
$10.4BFY to 2025-12-31
Biogen revenue
$9.9BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Alcon vs Biogen: every measure side by side
Measure Alcon Biogen
SectorHealth CareHealth Care
Country Switzerland United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$35.6Blower$37.1Bhigher
Revenue$10.4Bhigher$9.9Blower
Earnings$980Mlower$1.3Bhigher
Employees25,942higher7,500lower
Total assets$31.6Bhigher$29.4Blower
Valuation
P/E53.7lower109higher
P/S3.4lower3.7higher
P/B—2.0
Dividend yield—0.00%
Profitability
Operating margin13.1%—
Balance sheet
Net assets$22Bhigher$18.3Blower
Total liabilities$9.5Blower$11.2Bhigher
Total debt$4.7Blower$6.3Bhigher
Cash on hand$1.5Blower$3Bhigher
Price change
Today+0.64%higher-0.34%lower
1 year-2.82%lower+49.1%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Percentages are each holding's share of that investor's reported portfolio. Who owns ALC · Who owns BIIB

Further comparisons

Learn

Questions and answers

Which is bigger, Alcon or Biogen?

By market value, Biogen is the larger: $37.1B against $35.6B for Alcon. By revenue in its latest fiscal year, Alcon is the larger: $10.4B against $9.9B for Biogen.

Which has the higher P/E ratio?

Biogen: 109, against 53.7 for Alcon. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has more debt?

Biogen: $6.3B, against $4.7B for Alcon. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Alcon and Biogen?

None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Alcon and 4 hold Biogen.

Cite this page

Funkfolio, “Alcon vs Biogen”, data as of 18 November 2026. https://funkfolio.com/compare/alc-vs-biib

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.